AdipoPharma

Strasbourg, France · Founded 2017 · Privately Held (backing)

Developer of a peptide-based drug designed to offer treatment for patients suffering from type 2 diabetes. AdipoPharma is based in Strasbourg, France and was founded in 2017. Its last known valuation is $18.4 million. It has raised $34.5 million.

Last price · $/share

—

Implied valuation

$18.4M

Total raised

$34.5M

Last round

—

How much has AdipoPharma raised?

$34.5Macross 0 recorded rounds

Free account

More of AdipoPharma with a free account

·The complete investor list: 11 names
·Watch AdipoPharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AdipoPharma investors

11 investors are on record for AdipoPharma, including Bpifrance, Morningside Group, Good Growth Capital and Okeanos (United States).

For fundraisers

Raising for a company like AdipoPharma?

11 investors have backed AdipoPharma.

See all 11 investors →

Frequently asked about AdipoPharma

How much has AdipoPharma raised?: AdipoPharma has raised $34.5M in total across 0 recorded funding rounds.